Hi-CRATES CO.,LTD. (JPX: 4172.T) Stock Competitors & Peer Comparison

Hi-CRATES CO.,LTD. (JPX: 4172.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4172.T stands at 4.9B. In comparison, 6197.T has a market cap of 100.6B. Regarding current trading prices, 4172.T is priced at ¥2,211.00 on the JPX, while 6197.T trades at ¥1,111.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4172.T currently has a P/E ratio of 10.91, whereas 6197.T's P/E ratio is 27.22. In terms of profitability, 4172.T's ROE is +0.11%, compared to 6197.T's ROE of +0.16%. Regarding short-term risk, 4172.T is more volatile compared to 6197.T. This indicates higher risk in terms of short-term price fluctuations for 4172.T.Check 6197.T's competition here

Hi-CRATES CO.,LTD. (JPX: 4172.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4172.T stands at 4.9B. In comparison, 6099.T has a market cap of 47.5B. Regarding current trading prices, 4172.T is priced at ¥2,211.00 on the JPX, while 6099.T trades at ¥791.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4172.T currently has a P/E ratio of 10.91, whereas 6099.T's P/E ratio is 16.29. In terms of profitability, 4172.T's ROE is +0.11%, compared to 6099.T's ROE of +0.21%. Regarding short-term risk, 4172.T is less volatile compared to 6099.T. This indicates lower risk in terms of short-term price fluctuations for 4172.T.Check 6099.T's competition here

Hi-CRATES CO.,LTD. (JPX: 4172.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4172.T stands at 4.9B. In comparison, 6062.T has a market cap of 44.9B. Regarding current trading prices, 4172.T is priced at ¥2,211.00 on the JPX, while 6062.T trades at ¥1,369.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4172.T currently has a P/E ratio of 10.91, whereas 6062.T's P/E ratio is 12.08. In terms of profitability, 4172.T's ROE is +0.11%, compared to 6062.T's ROE of +0.17%. Regarding short-term risk, 4172.T is less volatile compared to 6062.T. This indicates lower risk in terms of short-term price fluctuations for 4172.T.Check 6062.T's competition here

Hi-CRATES CO.,LTD. (JPX: 4172.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4172.T stands at 4.9B. In comparison, 7071.T has a market cap of 36.6B. Regarding current trading prices, 4172.T is priced at ¥2,211.00 on the JPX, while 7071.T trades at ¥368.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4172.T currently has a P/E ratio of 10.91, whereas 7071.T's P/E ratio is 12.70. In terms of profitability, 4172.T's ROE is +0.11%, compared to 7071.T's ROE of +0.08%. Regarding short-term risk, 4172.T is less volatile compared to 7071.T. This indicates lower risk in terms of short-term price fluctuations for 4172.T.Check 7071.T's competition here

Hi-CRATES CO.,LTD. (JPX: 4172.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4172.T stands at 4.9B. In comparison, 2372.T has a market cap of 33.8B. Regarding current trading prices, 4172.T is priced at ¥2,211.00 on the JPX, while 2372.T trades at ¥2,790.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4172.T currently has a P/E ratio of 10.91, whereas 2372.T's P/E ratio is 131.60. In terms of profitability, 4172.T's ROE is +0.11%, compared to 2372.T's ROE of +0.11%. Regarding short-term risk, 4172.T is more volatile compared to 2372.T. This indicates higher risk in terms of short-term price fluctuations for 4172.T.Check 2372.T's competition here

Hi-CRATES CO.,LTD. (JPX: 4172.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4172.T stands at 4.9B. In comparison, 2374.T has a market cap of 29.9B. Regarding current trading prices, 4172.T is priced at ¥2,211.00 on the JPX, while 2374.T trades at ¥1,212.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4172.T currently has a P/E ratio of 10.91, whereas 2374.T's P/E ratio is 0.00. In terms of profitability, 4172.T's ROE is +0.11%, compared to 2374.T's ROE of +0.10%. Regarding short-term risk, 4172.T is more volatile compared to 2374.T. This indicates higher risk in terms of short-term price fluctuations for 4172.T.Check 2374.T's competition here

Hi-CRATES CO.,LTD. (JPX: 4172.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4172.T stands at 4.9B. In comparison, 9158.T has a market cap of 23.3B. Regarding current trading prices, 4172.T is priced at ¥2,211.00 on the JPX, while 9158.T trades at ¥784.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4172.T currently has a P/E ratio of 10.91, whereas 9158.T's P/E ratio is 8.16. In terms of profitability, 4172.T's ROE is +0.11%, compared to 9158.T's ROE of +0.09%. Regarding short-term risk, 4172.T is more volatile compared to 9158.T. This indicates higher risk in terms of short-term price fluctuations for 4172.T.Check 9158.T's competition here

Hi-CRATES CO.,LTD. (JPX: 4172.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4172.T stands at 4.9B. In comparison, 194A.T has a market cap of 10.9B. Regarding current trading prices, 4172.T is priced at ¥2,211.00 on the JPX, while 194A.T trades at ¥1,306.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4172.T currently has a P/E ratio of 10.91, whereas 194A.T's P/E ratio is 25.10. In terms of profitability, 4172.T's ROE is +0.11%, compared to 194A.T's ROE of +0.30%. Regarding short-term risk, 4172.T is less volatile compared to 194A.T. This indicates lower risk in terms of short-term price fluctuations for 4172.T.Check 194A.T's competition here

Hi-CRATES CO.,LTD. (JPX: 4172.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4172.T stands at 4.9B. In comparison, 7133.T has a market cap of 8.5B. Regarding current trading prices, 4172.T is priced at ¥2,211.00 on the JPX, while 7133.T trades at ¥1,199.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4172.T currently has a P/E ratio of 10.91, whereas 7133.T's P/E ratio is 16.91. In terms of profitability, 4172.T's ROE is +0.11%, compared to 7133.T's ROE of +0.20%. Regarding short-term risk, 4172.T is less volatile compared to 7133.T. This indicates lower risk in terms of short-term price fluctuations for 4172.T.Check 7133.T's competition here

Hi-CRATES CO.,LTD. (JPX: 4172.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4172.T stands at 4.9B. In comparison, 8769.T has a market cap of 8.1B. Regarding current trading prices, 4172.T is priced at ¥2,211.00 on the JPX, while 8769.T trades at ¥504.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4172.T currently has a P/E ratio of 10.91, whereas 8769.T's P/E ratio is 11.80. In terms of profitability, 4172.T's ROE is +0.11%, compared to 8769.T's ROE of +0.17%. Regarding short-term risk, 4172.T is less volatile compared to 8769.T. This indicates lower risk in terms of short-term price fluctuations for 4172.T.Check 8769.T's competition here

Hi-CRATES CO.,LTD. (JPX: 4172.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4172.T stands at 4.9B. In comparison, 160A.T has a market cap of 7.5B. Regarding current trading prices, 4172.T is priced at ¥2,211.00 on the JPX, while 160A.T trades at ¥2,080.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4172.T currently has a P/E ratio of 10.91, whereas 160A.T's P/E ratio is 6.37. In terms of profitability, 4172.T's ROE is +0.11%, compared to 160A.T's ROE of +0.23%. Regarding short-term risk, 4172.T is more volatile compared to 160A.T. This indicates higher risk in terms of short-term price fluctuations for 4172.T.Check 160A.T's competition here

Hi-CRATES CO.,LTD. (JPX: 4172.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4172.T stands at 4.9B. In comparison, 6059.T has a market cap of 6.8B. Regarding current trading prices, 4172.T is priced at ¥2,211.00 on the JPX, while 6059.T trades at ¥346.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4172.T currently has a P/E ratio of 10.91, whereas 6059.T's P/E ratio is 22.80. In terms of profitability, 4172.T's ROE is +0.11%, compared to 6059.T's ROE of +0.02%. Regarding short-term risk, 4172.T is more volatile compared to 6059.T. This indicates higher risk in terms of short-term price fluctuations for 4172.T.Check 6059.T's competition here

Hi-CRATES CO.,LTD. (JPX: 4172.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4172.T stands at 4.9B. In comparison, 2373.T has a market cap of 5.5B. Regarding current trading prices, 4172.T is priced at ¥2,211.00 on the JPX, while 2373.T trades at ¥401.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4172.T currently has a P/E ratio of 10.91, whereas 2373.T's P/E ratio is 51.73. In terms of profitability, 4172.T's ROE is +0.11%, compared to 2373.T's ROE of +0.02%. Regarding short-term risk, 4172.T is more volatile compared to 2373.T. This indicates higher risk in terms of short-term price fluctuations for 4172.T.Check 2373.T's competition here

Hi-CRATES CO.,LTD. (JPX: 4172.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4172.T stands at 4.9B. In comparison, 7091.T has a market cap of 5.4B. Regarding current trading prices, 4172.T is priced at ¥2,211.00 on the JPX, while 7091.T trades at ¥1,191.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4172.T currently has a P/E ratio of 10.91, whereas 7091.T's P/E ratio is 13.60. In terms of profitability, 4172.T's ROE is +0.11%, compared to 7091.T's ROE of +0.17%. Regarding short-term risk, 4172.T is less volatile compared to 7091.T. This indicates lower risk in terms of short-term price fluctuations for 4172.T.Check 7091.T's competition here

Hi-CRATES CO.,LTD. (JPX: 4172.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4172.T stands at 4.9B. In comparison, 7061.T has a market cap of 4.8B. Regarding current trading prices, 4172.T is priced at ¥2,211.00 on the JPX, while 7061.T trades at ¥562.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4172.T currently has a P/E ratio of 10.91, whereas 7061.T's P/E ratio is 15.88. In terms of profitability, 4172.T's ROE is +0.11%, compared to 7061.T's ROE of +0.08%. Regarding short-term risk, 4172.T is more volatile compared to 7061.T. This indicates higher risk in terms of short-term price fluctuations for 4172.T.Check 7061.T's competition here

Hi-CRATES CO.,LTD. (JPX: 4172.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4172.T stands at 4.9B. In comparison, 6557.T has a market cap of 4.5B. Regarding current trading prices, 4172.T is priced at ¥2,211.00 on the JPX, while 6557.T trades at ¥682.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4172.T currently has a P/E ratio of 10.91, whereas 6557.T's P/E ratio is 7.39. In terms of profitability, 4172.T's ROE is +0.11%, compared to 6557.T's ROE of +0.20%. Regarding short-term risk, 4172.T is less volatile compared to 6557.T. This indicates lower risk in terms of short-term price fluctuations for 4172.T.Check 6557.T's competition here

Hi-CRATES CO.,LTD. (JPX: 4172.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4172.T stands at 4.9B. In comparison, 9229.T has a market cap of 4.2B. Regarding current trading prices, 4172.T is priced at ¥2,211.00 on the JPX, while 9229.T trades at ¥133.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4172.T currently has a P/E ratio of 10.91, whereas 9229.T's P/E ratio is -2.55. In terms of profitability, 4172.T's ROE is +0.11%, compared to 9229.T's ROE of -0.23%. Regarding short-term risk, 4172.T is less volatile compared to 9229.T. This indicates lower risk in terms of short-term price fluctuations for 4172.T.Check 9229.T's competition here

Hi-CRATES CO.,LTD. (JPX: 4172.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4172.T stands at 4.9B. In comparison, 7037.T has a market cap of 3.9B. Regarding current trading prices, 4172.T is priced at ¥2,211.00 on the JPX, while 7037.T trades at ¥854.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4172.T currently has a P/E ratio of 10.91, whereas 7037.T's P/E ratio is 23.79. In terms of profitability, 4172.T's ROE is +0.11%, compared to 7037.T's ROE of +0.09%. Regarding short-term risk, 4172.T is less volatile compared to 7037.T. This indicates lower risk in terms of short-term price fluctuations for 4172.T.Check 7037.T's competition here

Hi-CRATES CO.,LTD. (JPX: 4172.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4172.T stands at 4.9B. In comparison, 7129.T has a market cap of 3.2B. Regarding current trading prices, 4172.T is priced at ¥2,211.00 on the JPX, while 7129.T trades at ¥1,164.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4172.T currently has a P/E ratio of 10.91, whereas 7129.T's P/E ratio is 62.96. In terms of profitability, 4172.T's ROE is +0.11%, compared to 7129.T's ROE of +0.05%. Regarding short-term risk, 4172.T is more volatile compared to 7129.T. This indicates higher risk in terms of short-term price fluctuations for 4172.T.Check 7129.T's competition here

Hi-CRATES CO.,LTD. (JPX: 4172.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4172.T stands at 4.9B. In comparison, 9220.T has a market cap of 3B. Regarding current trading prices, 4172.T is priced at ¥2,211.00 on the JPX, while 9220.T trades at ¥1,222.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4172.T currently has a P/E ratio of 10.91, whereas 9220.T's P/E ratio is 6.69. In terms of profitability, 4172.T's ROE is +0.11%, compared to 9220.T's ROE of +0.12%. Regarding short-term risk, 4172.T is more volatile compared to 9220.T. This indicates higher risk in terms of short-term price fluctuations for 4172.T.Check 9220.T's competition here

Hi-CRATES CO.,LTD. (JPX: 4172.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4172.T stands at 4.9B. In comparison, 2425.T has a market cap of 2.5B. Regarding current trading prices, 4172.T is priced at ¥2,211.00 on the JPX, while 2425.T trades at ¥670.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4172.T currently has a P/E ratio of 10.91, whereas 2425.T's P/E ratio is 21.98. In terms of profitability, 4172.T's ROE is +0.11%, compared to 2425.T's ROE of +0.04%. Regarding short-term risk, 4172.T is more volatile compared to 2425.T. This indicates higher risk in terms of short-term price fluctuations for 4172.T.Check 2425.T's competition here

Hi-CRATES CO.,LTD. (JPX: 4172.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4172.T stands at 4.9B. In comparison, 2435.T has a market cap of 2.4B. Regarding current trading prices, 4172.T is priced at ¥2,211.00 on the JPX, while 2435.T trades at ¥210.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4172.T currently has a P/E ratio of 10.91, whereas 2435.T's P/E ratio is 4.50. In terms of profitability, 4172.T's ROE is +0.11%, compared to 2435.T's ROE of +0.31%. Regarding short-term risk, 4172.T is more volatile compared to 2435.T. This indicates higher risk in terms of short-term price fluctuations for 4172.T.Check 2435.T's competition here

Hi-CRATES CO.,LTD. (JPX: 4172.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4172.T stands at 4.9B. In comparison, 189A.T has a market cap of 2.3B. Regarding current trading prices, 4172.T is priced at ¥2,211.00 on the JPX, while 189A.T trades at ¥1,001.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4172.T currently has a P/E ratio of 10.91, whereas 189A.T's P/E ratio is 10.45. In terms of profitability, 4172.T's ROE is +0.11%, compared to 189A.T's ROE of +0.10%. Regarding short-term risk, 4172.T is more volatile compared to 189A.T. This indicates higher risk in terms of short-term price fluctuations for 4172.T.Check 189A.T's competition here

Hi-CRATES CO.,LTD. (JPX: 4172.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4172.T stands at 4.9B. In comparison, 7083.T has a market cap of 2.2B. Regarding current trading prices, 4172.T is priced at ¥2,211.00 on the JPX, while 7083.T trades at ¥1,083.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4172.T currently has a P/E ratio of 10.91, whereas 7083.T's P/E ratio is 266.09. In terms of profitability, 4172.T's ROE is +0.11%, compared to 7083.T's ROE of +0.01%. Regarding short-term risk, 4172.T is less volatile compared to 7083.T. This indicates lower risk in terms of short-term price fluctuations for 4172.T.Check 7083.T's competition here

Hi-CRATES CO.,LTD. (JPX: 4172.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4172.T stands at 4.9B. In comparison, 6029.T has a market cap of 2.1B. Regarding current trading prices, 4172.T is priced at ¥2,211.00 on the JPX, while 6029.T trades at ¥199.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4172.T currently has a P/E ratio of 10.91, whereas 6029.T's P/E ratio is 12.63. In terms of profitability, 4172.T's ROE is +0.11%, compared to 6029.T's ROE of +0.10%. Regarding short-term risk, 4172.T is less volatile compared to 6029.T. This indicates lower risk in terms of short-term price fluctuations for 4172.T.Check 6029.T's competition here

Hi-CRATES CO.,LTD. (JPX: 4172.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4172.T stands at 4.9B. In comparison, 7062.T has a market cap of 2B. Regarding current trading prices, 4172.T is priced at ¥2,211.00 on the JPX, while 7062.T trades at ¥785.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4172.T currently has a P/E ratio of 10.91, whereas 7062.T's P/E ratio is 4.00. In terms of profitability, 4172.T's ROE is +0.11%, compared to 7062.T's ROE of +0.26%. Regarding short-term risk, 4172.T is more volatile compared to 7062.T. This indicates higher risk in terms of short-term price fluctuations for 4172.T.Check 7062.T's competition here

Hi-CRATES CO.,LTD. (JPX: 4172.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4172.T stands at 4.9B. In comparison, 9214.T has a market cap of 1.7B. Regarding current trading prices, 4172.T is priced at ¥2,211.00 on the JPX, while 9214.T trades at ¥1,294.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4172.T currently has a P/E ratio of 10.91, whereas 9214.T's P/E ratio is 21.43. In terms of profitability, 4172.T's ROE is +0.11%, compared to 9214.T's ROE of +0.11%. Regarding short-term risk, 4172.T is more volatile compared to 9214.T. This indicates higher risk in terms of short-term price fluctuations for 4172.T.Check 9214.T's competition here

Hi-CRATES CO.,LTD. (JPX: 4172.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4172.T stands at 4.9B. In comparison, 7362.T has a market cap of 1.3B. Regarding current trading prices, 4172.T is priced at ¥2,211.00 on the JPX, while 7362.T trades at ¥886.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4172.T currently has a P/E ratio of 10.91, whereas 7362.T's P/E ratio is 11.44. In terms of profitability, 4172.T's ROE is +0.11%, compared to 7362.T's ROE of +0.09%. Regarding short-term risk, 4172.T is more volatile compared to 7362.T. This indicates higher risk in terms of short-term price fluctuations for 4172.T.Check 7362.T's competition here